Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Gastric Cancer

  Free Subscription

Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    August 2020
  1. SHI S, Yang ZZ, Liu S, Yang F, et al
    PIWIL1 promotes gastric cancer via a piRNA-independent mechanism.
    Proc Natl Acad Sci U S A. 2020 Aug 26. pii: 2008724117.
    PubMed     Abstract available

    September 2019
  2. WROBLEWSKI LE, Choi E, Petersen C, Delgado AG, et al
    Targeted mobilization of Lrig1(+) gastric epithelial stem cell populations by a carcinogenic Helicobacter pylori type IV secretion system.
    Proc Natl Acad Sci U S A. 2019 Sep 5. pii: 1903798116.
    PubMed     Abstract available

    May 2019
  3. KAMADA T, Togashi Y, Tay C, Ha D, et al
    PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.
    Proc Natl Acad Sci U S A. 2019;116:9999-10008.
    PubMed     Abstract available

    February 2019
  4. SIERRA JC, Suarez G, Piazuelo MB, Luis PB, et al
    alpha-Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in Helicobacter pylori cagY.
    Proc Natl Acad Sci U S A. 2019 Feb 25. pii: 1814497116.
    PubMed     Abstract available

    February 2018
  5. YAMASHITA S, Kishino T, Takahashi T, Shimazu T, et al
    Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues.
    Proc Natl Acad Sci U S A. 2018;115:1328-1333.
    PubMed     Abstract available

    December 2016
  6. GAN J, Ke X, Jiang J, Dong H, et al
    Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-kappaB signaling.
    Proc Natl Acad Sci U S A. 2016 Dec 7. pii: 201618582.
    PubMed     Abstract available

    April 2016
  7. CLARK AJ, Wiley DT, Zuckerman JE, Webster P, et al
    CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing.
    Proc Natl Acad Sci U S A. 2016;113:3850-4.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.